Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies
Open Access
- 17 September 2015
- journal article
- review article
- Published by Hindawi Limited in Autoimmune Diseases
- Vol. 2015, 1-5
Abstract
Vitiligo, a depigmentary disorder, caused by the loss of melanocytes, affects approximately 1% of the world population, irrespective of skin type, with a serious psychological impact on the patient quality of life. So far, the origin of vitiligo has not been traced and the pathogenesis is complex, involving the interplay of a multitude of variables. Although there is no treatment that ensures the complete cure of the disorder, there are some pharmacological, phototherapy, and surgical therapies available. A series of variables can affect treatment outcome, such as individual characteristics, emotional issues, type of vitiligo, stability of the lesions, and immunological status. The present literature review identified the main immunological parameters associated with treatments for vitiligo. Cytotoxic CD8+ T lymphocytes are the main cell type involved in treatment success, as fewer cells in skin lesions are associated with better results. Other parameters such as cytokines and regulatory T cells may also be involved. Further clinical scientific studies are needed to elucidate the complex mechanisms underlying vitiligo and its treatments, in order to expand the range of therapeutic approaches for each individual case.Keywords
This publication has 38 references indexed in Scilit:
- Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two casesAnais Brasileiros de Dermatologia, 2013
- T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligoClinica Chimica Acta, 2013
- Modern vitiligo genetics sheds new light on an ancient diseaseThe Journal of Dermatology, 2013
- Dermal Mesenchymal Stem Cells (DMSCs) Inhibit Skin-Homing CD8+ T Cell Activity, a Determining Factor of Vitiligo Patients’ Autologous Melanocytes Transplantation EfficiencyPLOS ONE, 2013
- Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized studyBritish Journal of Dermatology, 2012
- Nonsegmental Vitiligo and Autoimmune MechanismDermatology Research and Practice, 2011
- Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligoExperimental Dermatology, 2010
- Treatment of Vitiligo on Difficult-to-Treat Sites Using Autologous Noncultured Cellular GraftingDermatologic Surgery, 2009
- Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?Experimental Dermatology, 2008
- Stigmatization experience, coping and sense of coherence in vitiligo patientsJournal of the European Academy of Dermatology and Venereology, 2007